Financial Performance - The total revenue for the third quarter was ¥289,137,508.42, representing a decrease of 26.53% compared to the previous quarter [20]. - The net profit attributable to shareholders of the listed company was ¥59,152,950.87, down 58.10% from the previous quarter [20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥54,410,014.11, a decrease of 60.05% compared to the previous quarter [20]. - The company reported a total profit of ¥334,621,662.96 for the period, down from ¥376,281,112.77 in the previous quarter [15]. - The company experienced a decrease in comprehensive income attributable to shareholders, totaling ¥285,890,455.63 for the quarter, compared to ¥321,964,378.52 in the previous quarter [15]. - The net profit for the period was CNY 334,765,260.53, down 11.03% from CNY 376,341,173.73 in the same quarter last year [32]. Research and Development - Total R&D expenses for the first nine months of 2023 reached ¥79,882,546.84, an increase of 33.97% compared to ¥59,627,214.97 in the same period of 2022 [7]. - Research and development expenses rose to CNY 79,882,546.84, an increase of 33.93% compared to CNY 59,627,214.97 in Q3 2022 [32]. - The company plans to expand its R&D office space, which contributed to a 68.46% increase in lease liabilities to ¥6,614,944.42 from ¥3,926,794.65 in the previous year [7]. Income and Expenses - Investment income surged to ¥12,855,969.32, a remarkable increase of 3230.34% from ¥386,025.67 in the previous year [7]. - Other income rose by 48.06% to ¥12,443,558.06, compared to ¥8,404,548.70 in the same period last year, attributed to increased government subsidies [7]. - The company received a total of ¥10,065.77 in non-operating income, which is a 141.77% increase from ¥4,163.42 in the previous year [7]. - The fair value change income was reported at ¥207,521.23, a 140.01% increase from a loss of -¥518,693.07 in the previous year [7]. - The company reported a 225.73% increase in construction in progress, reaching CNY 129,046,922.91, up from CNY 39,618,116.15 [23]. - The total non-operating income and expenses for the current period is ¥4,742,936.76, down from ¥21,501,262.81 in the previous period [47]. Taxation - The company reported a 54.57% decrease in taxes and surcharges, totaling ¥2,924,844.43, down from ¥6,438,740.19 in 2022 [7]. - The company’s tax expenses decreased by 30.07% to ¥34,550,284.25, down from ¥49,408,885.03 in the same period last year due to tax incentives for subsidiaries [7]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥268,428,729.92, an increase of 34.10% year-over-year [20]. - The cash and cash equivalents at the end of the period were ¥1,124,089,840.87, reflecting a net increase of ¥65,136,709.56 during the quarter [17]. - The total cash inflow from investment activities is ¥2,579,644,558.12, significantly higher than ¥272,279,745.92 in the previous period [57]. - The net cash flow from investment activities is -¥61,140,353.45, an improvement from -¥136,974,428.80 in the previous period [57]. - The total cash outflow from investment activities is ¥2,640,784,911.57, compared to ¥409,254,174.72 in the previous period [57]. - The cash received from other operating activities is ¥51,424,439.05, an increase from ¥24,263,422.75 in the previous period [57]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,324, with the largest shareholder holding 45.74% [7]. - The equity attributable to shareholders of the listed company was ¥3,164,940,315.71, up 4.75% from the end of the previous year [20]. - The total equity attributable to shareholders increased to CNY 3,164,940,315.71, up from CNY 3,021,380,860.08, marking a growth of 4.75% [37]. - Basic earnings per share for the third quarter were ¥0.15, down 61.54% compared to the previous quarter [20]. Liabilities - The total liabilities decreased to CNY 317,879,912.64 from CNY 368,196,680.46, reflecting a reduction of 13.56% [37]. - Accounts receivable increased significantly by 661.00% to CNY 10,347,714.43 from CNY 1,359,759.60 [23]. - Other non-current assets surged by 727.94% to CNY 28,614,348.68, compared to CNY 3,456,081.12 in the previous period [23].
美好医疗(301363) - 2023 Q3 - 季度财报